Infectious Disease Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: IF0E3CFE192FEN
Market Monitor Global

Abstracts

Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.

This report contains market size and forecasts of Infectious Disease Therapeutics in Global, including the following market information:

Global Infectious Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Infectious Disease Therapeutics market was valued at 47050 million in 2021 and is projected to reach US$ 60190 million by 2028, at a CAGR of 3.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Infectious Disease Therapeutics include Novartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals Inc., Merck & Co. Inc. and Boehringer Ingelheim GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Infectious Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Infectious Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Drugs
• Vaccines

Global Infectious Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Infectious Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)

• HIV/AIDS
• Influenza
• Hepatitis
• Malaria
• Tuberculosis
• Others

Global Infectious Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Infectious Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Infectious Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Infectious Disease Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis AG
• Gilead
• GlaxoSmithKline plc
• Janssen Pharmaceutical Inc.
• F. Hoffmann-La Roche Ltd.
• BioCryst Pharmaceuticals Inc.
• Merck & Co. Inc.
• Boehringer Ingelheim GmbH

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Infectious Disease Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Infectious Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INFECTIOUS DISEASE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Infectious Disease Therapeutics Market Size: 2021 VS 2028
2.2 Global Infectious Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Infectious Disease Therapeutics Players in Global Market
3.2 Top Global Infectious Disease Therapeutics Companies Ranked by Revenue
3.3 Global Infectious Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Infectious Disease Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Infectious Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Disease Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Infectious Disease Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Infectious Disease Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Infectious Disease Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Drugs
  4.1.3 Vaccines
4.2 By Type - Global Infectious Disease Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Infectious Disease Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Infectious Disease Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Infectious Disease Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Infectious Disease Therapeutics Market Size, 2021 & 2028
  5.1.2 HIV/AIDS
  5.1.3 Influenza
  5.1.4 Hepatitis
  5.1.5 Malaria
  5.1.6 Tuberculosis
  5.1.7 Others
5.2 By Application - Global Infectious Disease Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Infectious Disease Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Infectious Disease Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Infectious Disease Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Infectious Disease Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Infectious Disease Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Infectious Disease Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Infectious Disease Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Infectious Disease Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Infectious Disease Therapeutics Revenue, 2017-2028
  6.3.2 US Infectious Disease Therapeutics Market Size, 2017-2028
  6.3.3 Canada Infectious Disease Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Infectious Disease Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Infectious Disease Therapeutics Revenue, 2017-2028
  6.4.2 Germany Infectious Disease Therapeutics Market Size, 2017-2028
  6.4.3 France Infectious Disease Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Infectious Disease Therapeutics Market Size, 2017-2028
  6.4.5 Italy Infectious Disease Therapeutics Market Size, 2017-2028
  6.4.6 Russia Infectious Disease Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Infectious Disease Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Infectious Disease Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Infectious Disease Therapeutics Revenue, 2017-2028
  6.5.2 China Infectious Disease Therapeutics Market Size, 2017-2028
  6.5.3 Japan Infectious Disease Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Infectious Disease Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Infectious Disease Therapeutics Market Size, 2017-2028
  6.5.6 India Infectious Disease Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Infectious Disease Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Infectious Disease Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Infectious Disease Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Infectious Disease Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Infectious Disease Therapeutics Market Size, 2017-2028
  6.7.3 Israel Infectious Disease Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Infectious Disease Therapeutics Market Size, 2017-2028
  6.7.5 UAE Infectious Disease Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis AG
  7.1.1 Novartis AG Corporate Summary
  7.1.2 Novartis AG Business Overview
  7.1.3 Novartis AG Infectious Disease Therapeutics Major Product Offerings
  7.1.4 Novartis AG Infectious Disease Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Novartis AG Key News
7.2 Gilead
  7.2.1 Gilead Corporate Summary
  7.2.2 Gilead Business Overview
  7.2.3 Gilead Infectious Disease Therapeutics Major Product Offerings
  7.2.4 Gilead Infectious Disease Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Gilead Key News
7.3 GlaxoSmithKline plc
  7.3.1 GlaxoSmithKline plc Corporate Summary
  7.3.2 GlaxoSmithKline plc Business Overview
  7.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Major Product Offerings
  7.3.4 GlaxoSmithKline plc Infectious Disease Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline plc Key News
7.4 Janssen Pharmaceutical Inc.
  7.4.1 Janssen Pharmaceutical Inc. Corporate Summary
  7.4.2 Janssen Pharmaceutical Inc. Business Overview
  7.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Major Product Offerings
  7.4.4 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Janssen Pharmaceutical Inc. Key News
7.5 F. Hoffmann-La Roche Ltd.
  7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Major Product Offerings
  7.5.4 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 F. Hoffmann-La Roche Ltd. Key News
7.6 BioCryst Pharmaceuticals Inc.
  7.6.1 BioCryst Pharmaceuticals Inc. Corporate Summary
  7.6.2 BioCryst Pharmaceuticals Inc. Business Overview
  7.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Major Product Offerings
  7.6.4 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 BioCryst Pharmaceuticals Inc. Key News
7.7 Merck & Co. Inc.
  7.7.1 Merck & Co. Inc. Corporate Summary
  7.7.2 Merck & Co. Inc. Business Overview
  7.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Major Product Offerings
  7.7.4 Merck & Co. Inc. Infectious Disease Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Merck & Co. Inc. Key News
7.8 Boehringer Ingelheim GmbH
  7.8.1 Boehringer Ingelheim GmbH Corporate Summary
  7.8.2 Boehringer Ingelheim GmbH Business Overview
  7.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Major Product Offerings
  7.8.4 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Boehringer Ingelheim GmbH Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Infectious Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Infectious Disease Therapeutics Market Drivers in Global Market
Table 3. Infectious Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Infectious Disease Therapeutics in Global Market
Table 5. Top Infectious Disease Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Infectious Disease Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Infectious Disease Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Infectious Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Infectious Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Infectious Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Infectious Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Infectious Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Infectious Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Infectious Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Infectious Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Infectious Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Infectious Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Infectious Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Infectious Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Infectious Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Infectious Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Infectious Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Infectious Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Infectious Disease Therapeutics Product Offerings
Table 32. Novartis AG Infectious Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Gilead Corporate Summary
Table 34. Gilead Infectious Disease Therapeutics Product Offerings
Table 35. Gilead Infectious Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline plc Corporate Summary
Table 37. GlaxoSmithKline plc Infectious Disease Therapeutics Product Offerings
Table 38. GlaxoSmithKline plc Infectious Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Janssen Pharmaceutical Inc. Corporate Summary
Table 40. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product Offerings
Table 41. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 43. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product Offerings
Table 44. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. BioCryst Pharmaceuticals Inc. Corporate Summary
Table 46. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product Offerings
Table 47. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Merck & Co. Inc. Corporate Summary
Table 49. Merck & Co. Inc. Infectious Disease Therapeutics Product Offerings
Table 50. Merck & Co. Inc. Infectious Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Boehringer Ingelheim GmbH Corporate Summary
Table 52. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product Offerings
Table 53. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Infectious Disease Therapeutics Segment by Type in 2021
Figure 2. Infectious Disease Therapeutics Segment by Application in 2021
Figure 3. Global Infectious Disease Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Infectious Disease Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Infectious Disease Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Infectious Disease Therapeutics Revenue in 2021
Figure 8. By Type - Global Infectious Disease Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Infectious Disease Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Infectious Disease Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Infectious Disease Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Infectious Disease Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Infectious Disease Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Infectious Disease Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Infectious Disease Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Infectious Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Infectious Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Gilead Infectious Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline plc Infectious Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck & Co. Inc. Infectious Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)